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INTRODUCTION 
The Scientific Committee on Cosmetology was set up by Commission 
Decision 78/45/EEC of 19 December 1977 (OJ Ne L 13 of 17 January 1978, 
p. 24) in order to provide the Commission with informed opinions on any 
scientific and technical problems arising in connection with cosmetic 
products, and in particular on the substances used in their manufacture, 
on their composition and on the conditions for their use. 
The members of the Committee are independent scientists highly qualified 
in the fields of medicine, toxicology, biology, chemistry or other 
similar disciplines. 
The Committee is serviced by the Directorate-General for the 
Environment, Consumer protection and Nuclear safety. 
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SCIENTIFIC COMMITTEE ON COSMETOLOGY 
Notes of guidance for the toxicity testing of cosmetic ingredients 
(opinion expressed 28 June 1982) 
Definition 
"A cosmetic product means any substance or preparation intended for placing 
in contact with the various parts of the human body (epidermis, hair system, 
nails, lips and external genital organs) or with the teeth and mucous mem-
branes of the oral cavity with a view exclusively or principally to clean-
ing them, perfuming them or protecting them, in order to keep them in good 
condition, change their appearance or correct body odours" (Council Direc-
tive 76/768/EEC of 27 July 1976). 
Ingredients are defined as "any substances used in cosmetic products". 
Introduction 
Cosmetic products have a history covering many thousands of years with the 
use of many ingredients from plant, animal and mineral sources. Present-day 
use, particularly as toiletries, is extensive and affects most population 
groups, but the degree and nature of this use varies widely within diffe-
rent countries of the European Community. 
The purpose of this document is to give guidance to national and internatio-
nal authorities within the European Communities and to the person(s) respon-
sible for putting cosmetics on the market (manufacturers or importers 
within the European Community). 
These guidelines will apply mainly to new cosmetic ingredients and will also 
be adopted for other ingredients over which concern about safety-in-use has 
been brought to notice, bearing in mind then their past record in use and 
the relevant toxicity data already in existence. 
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They are drawn up in general terms and will require amendments in future 
as scientific knowledge advances. It is strongly advisable therefore that, 
whenever possible, the test proposals and procedures should be discussed 
in advance with official experts. 
In practice, cosmetic products have seldom been associated with serious 
hazards to health. However, this does not mean that cosmetics are safe in 
use, especially with regard to possible long-term effects,and this, to-
gether with the fact that the products may be used extensively over a large 
part of the human Life span, has created a need to insure, so far as 
possible, their safety-in-use by controlling the ingredient content and 
toxicity. 
The question of safety-in-use cannot be resolved by the restriction of 
ingredients to those used without known problems in the past, for the 
following reasons: first, previously used ingredients may become difficult 
to obtain for economic or legislative reasons; second, consumers now demand 
products with certain properties and this may require the use of new ingre-
dients. The toxicological data on such ingredients are often scanty, or 
absent, and the possible long-term effects from absorption unkown. This 
is not to say established products should necessarily present a hazard to 
health, or that knowledge gained from extensive usage by man should be 
ignored in the assessment of the safety of such ingredients. The important 
point is that safety assessment of all ingredients should be on an appro-
priate basis. The use of natural as opposed to man-made ingredients does 
not confer any degree of safety. Indeed some of the most toxic substances 
known are "natural" in origin and many plant derivatives may be potent 
allergenic substances. In addition the purity of "natural" ingredients is 
often difficult to establish or control. 
Testing of ingredients and products 
Following Article 2 of the Council Directive 76/768/EEC cosmetic products 
put on the market within the Community must not be liable to cause damage 
to human health when they are applied under normal conditions of use. 
However, the large number of products compared with the number of ingre-
dients creates severe problems for considering the safety of the former. 
Hence, it is more realistic to perform toxicity studies, particularly for 
long-term hazards, on ingredients rather than on products, as this avoids 
unnecessary and costly duplication of studies, particularly with those 
ingredients used in a wide range of products. However, the assessment of 
the safety of an ingredient will greatly depend on the types of products 
in which it is intended to be used. For example, a combination of ingre-
dients may alter the safety-in-use of the products. 
Another problem is that a product can undergo chemical modification during 
use, as for example with the oxidizing hair dyes, or that the degree of 
absorption of the ingredient of cosmetic products may be altered by the 
solvents and oils used. For these reasons, therefore, the testing programme 
may have to be designed to take these factors into account. 
Positive lists 
In article 11 of the Council Directive 76/768/EEC it is stated that "with-
out prejudice to Article 5 and not later than one year after expiry of the 
period laid down in Article 14 (1) for implementation of this Directive 
by the Member States, the Commission shall, on the basis of the results of 
the latest scientific and technical research, submit to the Council appro-
priate proposals for establishing lists of permitted substances". 
Categories of cosmetics 
The assessment of the safety of ingredients depends greatly on the manner 
in which the cosmetic products containing them are used. The type of product 
will determine the proposed and foreseeable sites of the body which the 
ingredients may reach, and the duration of contact. These factors are impoi— 
tant as they in turn will determine the amount of substance which may be 
absorbed through the skin or mucous membranes; they can also affect the 
quantity of ingredient applied to the contact surface. Soaps, for example, 
are applied in diluted form and, although the area of application may be 
extensive, the product is rapidly washed off. Sun-tanning products may be 
applied also over large surfaces of the body and the ingredients can re-
main in contact with the skin over several hours. Products used on the 
lips and in the mouth will be ingested in to some extent, so that gastro-
intestinal absorption may occur. Cosmetics used around the eyes and 
genital regions may come into contact with the conjunctiva or mucosa 
respectively, resulting in reactions due to the thin epithelial lining 
of these areas. 
Based on the type of product in which the ingredient is to be used, the 
intended sites of application or contact of the final product, other 
possible sites of contact, the area of the body exposed to the final pro-
duct, the expected time of contact and other factors, it may be convenient 
to devide cosmetics into the 8 following categories. 
1. Skin cosmetics - products rinsed off 
2. Skin cosmetics - products not rinsed off 
3. Eye cosmetics 
4. Hair cosmetics - products rinsed off 
5. Hair cosmetics - products not rinsed off 
6. Nai I cosmetics 
7. Cosmetics applied in or around the mouth 
8. Intimate cosmetics. 
Important considerations which determine the nature of the toxicity stu-
dies required and the interpretation of the results are not only the 
product category but also the presentation of the product, in particular 
whether it is formulated in solid, liquid, powder or aerosol form. 
Solid and liquid preparations intended for direct application will some-
times spread beyond their intended area of application. Hair preparations 
may enter the eyes, lipstick materials may be ingested; powders and aero-
sols may reach the atmosphere and may be inhaled. In choosing testing 
procedures therefore, one should have in mind not only the intended use, 
but also other foreseeable sites that the final product may reach under 
normal conditions of use. 
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Physical and chemical specifications 
The precise chemical nature of the ingredient and its structural formula* 
if it is known, should be identified. With regard to ingredients which 
cannot be defined in terms of their structural formula, but only by their 
method of preparation, the latter should be sufficiently detailed to enable 
judgement to be made of the probable structure and activity of the com-
pound. 
The degree of purity of each ingredient should be defined, as well as an 
indication of the nature of any impurities that may be present, and their 
concentration. 
Wherever possible, the substances tested in toxicity studies should be of 
the same specification as the substances used in the commercial products. 
Small changes in the nature of quantities of contaminants can considerably 
alter the toxicity of the substances. In general therefore the results of 
toxicity studies are relevant only when they are referable to the ingre-
dient (or product) as marketed, or to even purer batches as incorporated 
into commercial products. 
With a view to checking the chemical nature of the ingredient and its de-
gree of purity, its physico-chemical properties should be known and methods 
should be devised for identification, qualitative and quantitative control. 
Toxicity studies 
Some in vitro systems have been developed so that they can be used as 
screening tests to indicate the possibility of a long-term risk, but the 
results still have to be confirmed in mammals. Most of the adverse effects 
associated with cosmetics (for example erythema, oedema, allergic effects, 
or systemic toxicity) are such that they can only be demonstrated in mam-
mals. It remains desirable that such testing requirements should be res-
tricted to those studies which are necessary and appropriate in order to 
avoid unnecessary use of animals. As and when alternatives to animal stu-
dies become validated these should be used. Where possible, human observa-
tions can contribute to safety evaluation. 
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Toxicity studies in animals, especially with the higher doses employed, 
invariably invoke some reactions, many of them adverse.That is not to say 
that the same adverse effects will necessarly arise when the substance is 
a component of a cosmetic, applied topically to the skin or the mucosae. 
Consequently, it must be remembered that the interpretation of the results 
of toxicity tests in terms of the safety-in-use of the final product must 
be a matter for expert judgement. 
Observations in man 
Whilst it is recognized that for ethical reasons deliberate studies in man 
cannot be made compulsory, observations in man are nevertheless of impoi— 
tance in the extrapolation from animal data. It is desirable that informa-
tion, particularly on irritancy and potential sensitization, be obtained in 
man. Observations on persons occupationally exposed to the ingredients may 
assist in assessing any potential hazard. 
Pharmacological activity 
Ingredients should not demonstrate such a degree of pharmacological activity 
that cosmetics in which they occur could be classified as pharmaceutical 
preparations (see recital of the directive 76/768) (1). 
Studies required 
As ingredients and final products vary widely in their nature and mode of 
use, it is not possible to set out a single system of testing which will 
apply to all ingredients. The type of product in which an ingredient is to 
be used will also affect the possible risk for man. Hence different sets of 
toxicity studies may have to be carried out with the different categories 
of cosmetic products. Annex I indicates the appropriate toxicity studies 
for an ingredient, according to proposed use in different product catego-
ries. 
(1) OJ L 262, 27.9.1976, p. 169 
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Irritancy 
a^ £kÌD_Ì££ÌÌ§ÌÌ°Q_st udj.es 
These studies should be performed on all ingredients, with the exeption 
of oral preparations, and should be designed to show the degree of irri-
tancy at least at proposed levels of use in cosmetic products. Studies 
on the ingredient will indicate whether or not that ingredient will be 
suitable for use in a cosmetic, whilst testing of the final product is 
necessary to ensure that irritancy is not increased by the vehicle or 
by other ingredients. Both the ingredient and the final product should 
be tested with at least one application to intact and abraded skin. In 
animals the rabbit remains the species of choice. Testing in human 
volunteers may provide valuable supplementary evidence and confirmation. 
b) Êuê_Í££ÍÍãÍÍ2D_§tu^ÍêS 
These are basically an extension of skin irritancy studies for ingre-
dients intended for use in products which may be applied in or around 
the eye, or which may enter the eye during normal application (for 
example shampoos). Hence these studies are not necessary when the in-
gredient has been shown to be a skin irritant. A suitable animal species 
(such as the rabbit) should be used, and the results of instillation in 
the eye of the ingredients in a suitable vehicle, and the final product, 
followed over a number of days. For ingredients or final products used 
irregularly (for example insect repellents and hair dyes) a single 
application is sufficient. Local anaestheti c properties should also be 
looked for where preparations may enter the eye. 
As soon as acceptable in vitro tests for eye irritation have been devised 
and validated these should be substituted for those in the intact animal. 
°) §E§£ÍÍÍ£_Q!eS2£aD§§_i££ÍÍ3tion 
Where products are intended to come into contact with mucous membranes 
more specific studies are required, because of the greater permeability 
and sensitivity of these areas. These Studies are not necessary when the 
ingredient or product has been shown to be a skin irritant. 
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Sensitisation studies 
These studies are essential for ingredients. Careful animal studies should 
virtually exclude the possibility that a powerfully allergenic substance 
might find its way into cosmetic products. The studies should involve the 
administration of the test substance to guinea pigs over a number of days 
followed by a further single administration after a non treatment period 
to assess if sensitisation has occured. Observations in man are also of 
great value in the evaluation of the allergic potential of cosmetics. 
Phototoxicity and photosensitisation 
Studies of phototoxicity and photosensitisation are required for certain 
ingredients where knowledge of the chemical structure indicates a possible 
hazard. In some instances (as with sunscreening agents) such studies should 
be performed where the risk could be greater in view of the mode of use. 
The techniques to be followed should be agreed beforehand with the appro-
priate authorities. 
Absorption, kinetics and metabolism 
Adequate absorption studies after dermal application and estimation of the 
amount of the ingredient absorbed and excreted are in most cases essential, 
supplemented where possible with adequate information of the metabolic 
changes undergone by the ingredient in the body. A knowledge of the degree 
of tissue storage of the ingredient and its metobolites might also be 
necessary. Acute and subacute dermal toxicity studies may also be useful 
to give an indication of the level of absorption from dermal application. 
If there is evidence of significant absorption via the skin, studies for 
systemic toxicity should be performed. The main route of administration in 
their toxicity studies should mimic human exposure. With most cosmetic 
products this will be dermal application. 
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When considering dermal absorption studies, it should be borne in mind that 
the solvent and other ingredients used may affect the amount of absorption 
so that it should be related to the vehicle ultimately to be used. The degree 
of absorption in man will depend upon the part of the body exposed to the 
product as well as to the potential total surface of the body which the 
product may reach. This will be relevant to the evaluation of the results 
of the absorption studies. Especially with products which are not rinsed 
off, information on the rate of absorption is essential. 
When products are applied to the lips or used in the mouth small quantities 
of the products are ingested. Hence the ingredients used in such products 
need to be investigated as other ingested chemicals. Special attention has 
to be given also to intimate cosmetics. Due to the thin epithelial lining 
of the mucosa the absorption rate of such cosmetics may be relatively high. 
Ingredients used in aerosols or powders may be inhaled. Particles of less 
than 10 microns in size may well be absorbed through the alveolar lining 
whilst a proportion of the particles trapped in bronchi or the upper respi-
ratory tract will subsequently be swallowed and may be absorbed from the 
gastro-intestinal tract. Hence absorption studies are required with this 
type of products. 
Mutageni city 
Mutagenesis refers to those changes in the genetic material of cells brought 
about by chemicals, whereby succeeding cells differs in a permanent and 
heritable way from their predecessors. Apart from the implications of expo-
sure to chemical substances for future generations if genetic'diseases are 
induced there is evidence that somatic cell mutations (as opposed to germ 
cell mutations) may be associated with the production of cancer. It is there-
fore required that, if no long-term study is available, any ingredient for 
cosmetic products should be investigated for mutagenic potential by testing 
procedures which cover both gene and chromosome damage, both in vitro and 
in vivo. A battery of tests in vitro is suggested, such as the Ames-test, 
with and without microsomal activation, evidence for DNA repair of unsche-
duled DNA synthesis, evidence for covalent binding to DNA protein and in 
vitro cell transformation and sister chromatid exchange, in vivo tests such 
as the micro nucleus test and the sex­linked recessive lethal test in 
Drosophila melanogaster. 
Oral studies 
a) Acute 
The acute toxicity is used for the classification and labelling of in­
gredients. Besides the quantitative expressure of acute toxicity (as 
LD­ ) the ill­effects that are noticed are of importance. The results 
of acute toxicity studies following oral administration of the ingre­
dients are valuable for the design of further studies. 
b ) Shortiterm_28_days 
In short­term toxicity experiments the effects of the administration of 
multiple doses over short periods of time are studied. They provide basic 
information on the systemic toxicity of ingredients. 
Where ingredients are used in products which are applied to the skin or 
the hair and then rinsed off after a short time, the opportunities for 
absorption of individual ingredients are minimal and therefore systemic 
toxicity does not play a major role. The absorption rate may be also 
slight from nail­cosmetics. Short­term studies alone may therefore be 
adequate for such products. The results of this study are also valuable 
for the design of further studies. 
The primary objective of the 90­day study is the characterization of the 
toxicological effect of an ingredient following repeated exposure over 
a significant fraction of the life span. Such studies provide informa­
tion on the toxic effects of the test compound, on dose­response rela­
tionships and on the effect­ and no­effect level. 
These studies are necessary where there is a possibility of regular 
ingestion and in certain cases when absorption takes place. Such studies 
should be carried out in at least one species. 
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d) Çh£2QÍ£_£2£Í£ÍI^_ãQ2L£§££ÍQ222QÍ£Í£¥_§Íy2'i_es 
When there is a possibility of continuous and prolonged absorption of 
the ingredient, the short­term toxicity studies should be completed by 
long­term feeding studies to investigate possible long­term effects. 
Such testing in animals requires exposure to the test substance at appro­
priate dosages for the major part of lifespan of the test animals. The 
objective is to assess potential toxicity in animals as the results of 
long­term low­level exposure, which would not be detected in short­term 
studies. It is generally acknowledged that, with the exception of cancer 
and certain other irreversible forms of toxicity, adequate short­term 
testing will detect most of the toxic effects. Generally, the aim is to 
establish a no adverse effect level which may be useful for setting 
acceptable daily exposure. It is unrealistic to require long­term toxi­
city studies for the majority of the ingredients at the present time. 
However, substances found positive in mutagenicity studies require life­
time studies, with special emphasis on carcinogenicity. Other relevant 
factors are: the chemical structure, the duration of exposure, the area 
exposed, absorption and type of ingredient and in exceptional cases the 
cosmetic products. Especially when cosmetic products are applied in or 
around the mouth long­term oral studies may be required. 
Dermal Toxicity studies 
These studies are particularly applicable to cosmetic products. In general, 
acute dermal studies should be performed on all cosmetic ingredients. These 
studies may indicate whether significant absorption takes place at high 
concentrations. They may also provide evidence of the hazard to man of 
excessive exposure, whether occupationally, accidentally or through misuse. 
They also furnish preliminary information for choosing the dosage ranges 
for short­ and long­term tests in order to determine the lowest dose which 
induces an adverse toxic response and the highest dose at which no effect 
is observed. 
When no data exist on absorption, short­term dermal toxicity studies are 
required for all cosmetics applied on the skin and hair. The primary aim is 
to study the systemic toxicity after dermal application. These studies are 
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intended to detect functional and/or histopathological changes in organs 
and tissue of the animal exposed to an ingredient for periods up to 90 days. 
In terms of human experience these studies have to predict the adverse 
effects produced by repeated exposure at dose levels below those which 
cause toxic effects. 
To mimic human exposure dermal toxicity and carcinogenicity studies have 
to be carried out in animals by continuous and prolonged exposure. When 
long-term effects on the skin can be expected, these studies are particu-
larly necessary. However, when systemic toxicity due to absorption from the 
skin is suspected, these dermal studies may (in exceptional cases) be re-
placed, for practical purposes, by long-term oral studies. 
Inhalation studies 
Studies are required whenever the ingredient could be inhaled, as for ins-
tance when it is to be delivered from aerosols or when in powder form. As 
a minimum, short-term studies (28 days) should be available for all ingre-
dienst which may be inhaled. Depending on the chemical structure and re-
sults of preliminary experiments, even long-term inhalation studies may be 
required in some circumstances. 
Appropriate measurements of particle size distribution, concentration and 
total dose are needed. These will indicate the likelihood of absorption 
through the lungs, but it should be remembered that even with the larger 
particle size considerable nasal deposition with subsequent swallowing 
occurs. Consultation on the design of the experiment with the authorities 
is desirable. 
Teratology and reproduction 
Studies on teratogenesis and reproduction are necessary for those ingre-
dients or cosmetic products which are absorbed or ingested to study the 
probability that a substance possesses teratogenic potential. 
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When an ingredient is ingested or absorbed, it is also necessary to obtain 
an indication of the potential effects on reproductive performance. A repro­
duction study is designed to provide information on fertility and general 
reproduction performance, particularly on gonadal function, oestrous cycles, 
mating behaviour, conception rates and the early stages of gestation. The 
reproduction studies can be carried out in parallel with the long­term toxi­
city studies. 
Special studies 
If the results of the acute, short­term or long­term toxicity tests or the 
chemical structure or properties of an ingredient suggest particular hazards, 
it may be necessary to carry out special investigations, to exclude neuro­
toxicity, hormonal activity, behavioural effects and immunosuppression. In 
such cases there should be consultation with the authorities. 
Testing procedures 
Protocols of the toxicological studies mentioned in these guidelines and 
in Annex I and II will be provided ata later stage. Toxicological testing 
should be performed according to internationally accepted procedures. Fur­
ther guidance shall be given in a supplementary annex. 
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Annex I 
Progression of safety testing 
The animal studies and observations in man mentioned below are meant to be 
only an inventory of the several types of tests which should be carried out 
in the assessment of the safety of ingredients or of final cosmetic products. 
The scheme has to be used as flexible as possible. Each ingredient or final 
product must be considered on its merits. It is impossible to lay down a 
scheme of investigation which is applicable to all. The precise pattern of 
tests required in a particular case is always a matter of discussion between 
the manufacturer or importer and the national or international agency con-
cerned. No booklet or scheme can replace this essential dialogue. 
The following investigations at least should be carried out with ingredients: 
1. Acute oral and dermal toxicity 
2. Dermal or mucous membrane irritation 
3. Sensitization 
4 . Shor t - te rm o r a l t o x i c i t y (28 days) 
5. Mutagenicity. 
Special emphasis should also be given to absorption by the skin or mucous 
membranes. 
The concentration of the ingredient in the end product, the intended and 
potential sites of application, the level of exposure, the presentation of 
the product (solid, liquid, powder or aerosol) and the expected duration of 
contact, should define the appropriate tests. For example, data on percu-
taneous absorption may eliminate the need for some of the tests. 
Interaction of ingredients in the final product is also possible and so it 
is advisable to study dermal or mucous membrane irritation and sensitization 
with the final products. 
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Annex II 
Animal studies for ingredients related to their proposed use. (x) 
C a t e g o r y o f c o s m e t i c p r o d u c t 
1 . S k i n - r i n s e d of f p roduc ts 
2 . S k i n - not r insed off p roduc ts 
3 . Eye c o s m e t i c s 
4 . H a i r - r i n s e d o f f p r o d u c t s 
5 . H a i r - not r i nsed off products 
6 . N a i l c o s m e t i c s 
7 . Mouth c o s m e t i c s 
8 . I n t i m a t e c o s m e t i c s 
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: wanted 
: not necessary 
: depending on some circumstances 
: only when no data on absorption are available 
(x) 
In addition it is desirable that information on skin/mucous membrane and 
eye irritation, sensitization and absorption should be obtained from obser­
vations in man, especially for the final products. 
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